Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001714899-22-000094
Filing Date
2022-06-06
Accepted
2022-06-06 20:08:44
Documents
1
Period of Report
2022-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165456050784142.html 4  
1 FORM 4 wf-form4_165456050784142.xml 4 5901
  Complete submission text file 0001714899-22-000094.txt   7302
Mailing Address 940 WINTER STREET PERKINELMER, INC. LEGAL DEPARTMENT WALTHAM MA 02451
Business Address
SATO VICKI L (Reporting) CIK: 0001197020 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 22999538

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)